- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- IGM Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- IGM Biosciences Inc Clinical Update Conference Call TranscriptJun 02, 2023
- IGM Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- IGM Biosciences Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 26, 2023
- Q4 2022 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2023$17.02 (-1.45%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- IGM Biosciences Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- IGM Biosciences Inc to Discuss Global Collaboration Agreement with Sanofi - Conference Call TranscriptMar 29, 2022
- IGM Biosciences Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- IGM Biosciences Inc to Discuss IGMS ASH Data - Conference Call TranscriptDec 12, 2021
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- IGM Biosciences Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 04, 2021
- Q4 2020 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2021$75.06 (+1.86%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call TranscriptJan 12, 2021
- IGM Biosciences Inc Review of IGM-2323 Data Presented at the 62nd Annual ASH Meeting - Conference Call TranscriptDec 05, 2020
- IGM Biosciences Inc at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- IGM Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- IGM Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- IGM Biosciences Inc Extraordinary Shareholders Meeting TranscriptJul 30, 2020
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Q4 2019 IGM Biosciences Inc Earnings Call TranscriptMar 26, 2020$43 (-9.11%)Earnings
- IGM Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
IGM Biosciences Inc Review of IGM-2323 Data Presented at the 62nd Annual ASH Meeting - Conference Call Transcript
Good day, everyone, and welcome to the IGM Biosciences conference call and webcast to review the IGM-2323 data presented today at the 62nd Annual ASH meeting. Today's call is being recorded. (Operator Instructions)
At this time, I would now like to turn the call over to Fred Schwarzer, Chief Executive Officer.
Thank you, operator, and welcome to all of you joining us today. I would like to thank you for taking time on your Saturday to join this presentation. All of us at IGM have been eagerly awaiting this day for 15 months ever since we dosed our first patient last year, and we are very excited and pleased to share our excellent initial efficacy and safety data from the clinical trial of IGM-2323.
This presentation contains certain forward-looking statements. And we must advise you that these forward-looking statements are subject to many factors which are beyond our control, and they should not be relied upon as predictions of future events. In this regard, we direct
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)